During the past decade, Saint Mary Medical and Regional Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 18 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Mary Medical and Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "NRG Oncology" with 2 trials sponsored and "Dendreon" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary Medical and Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary Medical and Regional Cancer Center" are "Breast Adenocarcinoma" (3 trials), "HER2/Neu Negative" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Recurrent Melanoma" (3 trials) and "Stage IIA Breast Cancer" (3 trials). Many other conditions were trialed in "Saint Mary Medical and Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Saint Mary Medical and Regional Cancer Center" are "Drug" (19 trials), "Other" (17 trials), "Biological" (11 trials), "Radiation" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Paclitaxel" (5 trials), "Bevacizumab" (4 trials), "Carboplatin" (4 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary Medical and Regional Cancer Center" are 13 trials for "All" genders, 8 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Mary Medical and Regional Cancer Center". undefined are not yet recruiting, 1 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Saint Mary Medical and Regional Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary Medical and Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".